España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Inozyme Pharma
INZY
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.35
-0.01
-0.74%
At close: -
$1.38
0.03
2.22%
After Hours: 4:41 PM EDT
Get Report
Comment
Inozyme Pharma (INZY) Forecast
News
Earnings
Inozyme Pharma (INZY) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Inozyme Pharma (NASDAQ:INZY) Stock
Inozyme Pharma Stock (NASDAQ: INZY)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, January 13, 2025
Inozyme Pharma shares are trading lower after...
Benzinga Newsdesk
Piper Sandler Maintains Overweight on Inozyme...
Benzinga Newsdesk
Wells Fargo Maintains Overweight on Inozyme P...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Inozyme ...
Benzinga Newsdesk
Friday, January 10, 2025
HC Wainwright & Co. Maintains Buy on Inozyme ...
Benzinga Newsdesk
Inozyme Pharma Announces Interim Data For INZ...
Benzinga Newsdesk
Wednesday, November 06, 2024
HC Wainwright & Co. Reiterates Buy on Inozyme...
Benzinga Newsdesk
Needham Reiterates Buy on Inozyme Pharma, Mai...
Benzinga Newsdesk
Tuesday, November 05, 2024
Inozyme Pharma Q3 EPS $(0.39) Beats $(0.44) E...
Benzinga Newsdesk
Friday, October 25, 2024
Needham Reiterates Buy on Inozyme Pharma, Mai...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Inozyme...
Benzinga Newsdesk
Thursday, October 24, 2024
Inozyme Pharma Reports Interim Data From Phas...
Benzinga Newsdesk
Thursday, October 17, 2024
Inozyme Pharma Announces Presentation Of Inte...
Benzinga Newsdesk
Monday, September 30, 2024
Wedbush Reiterates Outperform on Inozyme Phar...
Benzinga Newsdesk
Thursday, September 26, 2024
Inozyme Pharma Presents New Data At ASBMR 202...
Benzinga Newsdesk
Thursday, September 12, 2024
Why Analyst Says Rare Disease-Focused Inozyme Pharma Stock 'Could Be Worth A Look'
Vandana Singh
This AutoNation Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Avi Kapoor
Stifel Initiates Coverage On Inozyme Pharma w...
Benzinga Newsdesk
Monday, August 19, 2024
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
ZIM Integrated Shipping Services Posts Upbeat Earnings, Joins fuboTV, Foghorn Therapeutics And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Tuesday, August 13, 2024
Jefferies Assumes Inozyme Pharma at Buy, Rais...
Benzinga Newsdesk
Thursday, August 08, 2024
HC Wainwright & Co. Reiterates Buy on Inozyme...
Benzinga Newsdesk
Tuesday, August 06, 2024
Needham Reiterates Buy on Inozyme Pharma, Mai...
Benzinga Newsdesk
Inozyme Pharma Q2 EPS $(0.44) Misses $(0.39) ...
Benzinga Newsdesk
Friday, July 26, 2024
Wedbush Reiterates Outperform on Inozyme Phar...
Benzinga Newsdesk
Thursday, July 25, 2024
Inozyme Pharma Announces Preclinical Data Sho...
Benzinga Newsdesk
Tuesday, July 02, 2024
HC Wainwright & Co. Reiterates Buy on Inozyme...
Benzinga Newsdesk
Inozyme Pharma shares are trading higher afte...
Benzinga Newsdesk
Inozyme Pharma Announces FDA Fast Track Desig...
Benzinga Newsdesk
Thursday, May 30, 2024
Wells Fargo Initiates Coverage On Inozyme Pha...
Benzinga Newsdesk
Thursday, May 23, 2024
Inozyme Pharma To Present Phase 1/2 Trial Dat...
Benzinga Newsdesk
Wednesday, May 08, 2024
Needham Reiterates Buy on Inozyme Pharma, Mai...
Benzinga Newsdesk
Tuesday, May 07, 2024
Inozyme Pharma Q1 EPS $(0.38) Misses $(0.36) ...
Benzinga Newsdesk
Monday, April 29, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Wednesday, April 10, 2024
Needham Reiterates Buy on Inozyme Pharma, Mai...
Benzinga Newsdesk
Tuesday, April 09, 2024
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
B of A Securities Maintains Buy on Inozyme Ph...
Benzinga Newsdesk
Needham Reiterates Buy on Inozyme Pharma, Mai...
Benzinga Newsdesk
Monday, April 08, 2024
Inozyme Pharma Announces Topline Data from On...
Benzinga Newsdesk
Thursday, March 28, 2024
Top 5 Health Care Stocks That May Plunge In March
Avi Kapoor
Tuesday, March 26, 2024
Inozyme Pharma shares are trading higher afte...
Benzinga Newsdesk
Inozyme Pharma To Report Topline Data From On...
Benzinga Newsdesk
Wednesday, March 13, 2024
HC Wainwright & Co. Maintains Buy on Inozyme ...
Benzinga Newsdesk
Tuesday, March 12, 2024
Inozyme Pharma: Q4 Earnings Insights
Benzinga Insights
Needham Reiterates Buy on Inozyme Pharma, Mai...
Benzinga Newsdesk
Inozyme FY23 EPS $(1.37) Vs $(1.78) YoY; Cash...
Benzinga Newsdesk
Tuesday, January 30, 2024
Wedbush Reiterates Outperform on Inozyme Phar...
Benzinga Newsdesk
Wednesday, November 08, 2023
Needham Reiterates Buy on Inozyme Pharma, Mai...
Benzinga Newsdesk
Tuesday, November 07, 2023
Inozyme Pharma Q3 EPS $(0.29) Beats $(0.32) E...
Benzinga Newsdesk
Tuesday, October 10, 2023
Inozyme Pharma Highlights Inclusion Of Genera...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
